In contrast to that, CRC tumors highly infiltrated by CD8+ T cells (categories 3 and 4) exhibit no significant difference in their pathway enrichment, when comparing between samples categorized in low (category 3) and high (category 4) myeloid and T cell overlap (data not shown). The gene discussed is CD8A; the disease is colorectal carcinoma.